They are a viable alternative to weight loss medications as they address the underlying issues that lead to metabolic dysfunction in the first place
Int J Obes (Lond) 38 , 784793, (2014)
Managing diabetes, losing excess weight, and improving overall cardiometabolic health are all brain healthy, and if GLP-1 RAs can help with these, shouldnt they be brain healthy as well
The trial did have a conflict of interest in that it received support from a company that provides Setria, but it was also a randomized, double-blinded, and placebo-controlled trial with sound methods
* This does not guarantee coverage
Meanwhile, the federal lawsuit involving Ozempic is still pending, and more consumers can join in the federal MDL